Daiichi Sankyo, Lilly Explore Pharmacogenomic Marker For Prasugrel
This article was originally published in PharmAsia News
Executive Summary
A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era